Clinical trial NCT01644734: Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test
Official title: MATHS: Assessment of Health-status of Patients With COPD on MAintenance THerapy With Spiriva® HH Measured by CAT Test
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Pulmonary Disease, Chronic Obstructive
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
Collaborators: name: Pfizer
First posted: 2012-07-19
Enrollment: 1328
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP

Brief summary: To evaluate the early (3-month) impact of the long-acting anticholinergic Spiriva HH maintenance treatment on the COPD symptoms using the novel COPD Assessment test (CAT) in the real life setting of COPD patients, previously treated with short-acting bronchodilator on regular or as-needed basis.


Eligibility criteria: Inclusion criteria:

* Male and female ambulatory outpatients being seen in a participating physicians office for routine care,
* Patients with a clinical diagnosis of COPD (all stages according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010) being treated with long-acting anticholinergic (Tiotropium, Spiriva® HandiHaler® ) as maintenance therapy within the product label and a maximum of the last 4 weeks (0.-28. days before Visit 1),
* Patients previously treated with short-acting bronchodilators on regular or as-needed basis for at least 3 months before change to long-acting anticholinergic treatment,
* Patient fluent in language of questionnaire and having the cognitive and functional abilities required to fill in the questionnaire alone.

Exclusion criteria:

* Uncooperative patients as judged by the physician,
* Patients with any conditions excluded as per Country specific package insert,
* Patients currently enrolled in any clinical trial,
* Patients with COPD exacerbation or any acute disease in the last 3 months before Visit 1.

Primary outcomes:
measure: Number of Patients Maintaining or Improving Their Health Status
timeFrame: Baseline, 3 months
Secondary outcomes:
measure: Change in the Total CAT Score (Value Baseline Minus 3 Months)
timeFrame: Baseline, 3 months
Other outcomes:
Locations:
city: Andrychow
country: Poland
facility: Boehringer Ingelheim Investigational Site 236
city: Bialystok
country: Poland
facility: Boehringer Ingelheim Investigational Site 170
city: Bialystok
country: Poland
facility: Boehringer Ingelheim Investigational Site 184
city: Bialystok
country: Poland
facility: Boehringer Ingelheim Investigational Site 240
city: Bialystok
country: Poland
facility: Boehringer Ingelheim Investigational Site 44
city: Bialystok
country: Poland
facility: Boehringer Ingelheim Investigational Site 84
city: Bielsko-Biala
country: Poland
facility: Boehringer Ingelheim Investigational Site 33
city: Bielsko-Biala
country: Poland
facility: Boehringer Ingelheim Investigational Site 34
city: Bielsko-Biala
country: Poland
facility: Boehringer Ingelheim Investigational Site 35
city: Biskupiec
country: Poland
facility: Boehringer Ingelheim Investigational Site 79
city: Bochnia
country: Poland
facility: Boehringer Ingelheim Investigational Site 116
city: Brzesko
country: Poland
facility: Boehringer Ingelheim Investigational Site 115
city: Brzesko
country: Poland
facility: Boehringer Ingelheim Investigational Site 138
city: Brzeziny
country: Poland
facility: Boehringer Ingelheim Investigational Site 185
city: Brzozow
country: Poland
facility: Boehringer Ingelheim Investigational Site 90
city: Bydgoszcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 105
city: Bydgoszcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 119
city: Bydgoszcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 123
city: Bydgoszcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 222
city: Bydgoszcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 27
city: Chelmsko Slaskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 11
city: Chelm
country: Poland
facility: Boehringer Ingelheim Investigational Site 21
city: Chelm
country: Poland
facility: Boehringer Ingelheim Investigational Site 22
city: Chodziez
country: Poland
facility: Boehringer Ingelheim Investigational Site 233
city: Chojnice
country: Poland
facility: Boehringer Ingelheim Investigational Site 226
city: Chorzow
country: Poland
facility: Boehringer Ingelheim Investigational Site 149
city: Chorzow
country: Poland
facility: Boehringer Ingelheim Investigational Site 153
city: Ciechanow
country: Poland
facility: Boehringer Ingelheim Investigational Site 88
city: Czarnkow
country: Poland
facility: Boehringer Ingelheim Investigational Site 232
city: Czestochowa
country: Poland
facility: Boehringer Ingelheim Investigational Site 229
city: Czestochowa
country: Poland
facility: Boehringer Ingelheim Investigational Site 4
city: Dabrowa Gornicza
country: Poland
facility: Boehringer Ingelheim Investigational Site 23
city: Domaradz
country: Poland
facility: Boehringer Ingelheim Investigational Site 92
city: Dziergowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 246
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 133
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 134
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 136
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 155
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 156
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 20
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 234
city: Gdansk
country: Poland
facility: Boehringer Ingelheim Investigational Site 31
city: Gdynia
country: Poland
facility: Boehringer Ingelheim Investigational Site 41
city: Gliwice
country: Poland
facility: Boehringer Ingelheim Investigational Site 217
city: Glucholazy
country: Poland
facility: Boehringer Ingelheim Investigational Site 247
city: Gora
country: Poland
facility: Boehringer Ingelheim Investigational Site 85
city: Gorzow Wielkopolski
country: Poland
facility: Boehringer Ingelheim Investigational Site 50
city: Grodzisk Mazowiecki
country: Poland
facility: Boehringer Ingelheim Investigational Site 174
city: Grodzisk Mazowiecki
country: Poland
facility: Boehringer Ingelheim Investigational Site 176
city: Gryfice
country: Poland
facility: Boehringer Ingelheim Investigational Site 56
city: Jaroslaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 179
city: Jaslo
country: Poland
facility: Boehringer Ingelheim Investigational Site 108
city: Jaslo
country: Poland
facility: Boehringer Ingelheim Investigational Site 225
city: Jaslo
country: Poland
facility: Boehringer Ingelheim Investigational Site 8
city: Jedrzejow
country: Poland
facility: Boehringer Ingelheim Investigational Site 243
city: Jelenia Gora
country: Poland
facility: Boehringer Ingelheim Investigational Site 148
city: Katowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 162
city: Katowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 163
city: Katowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 164
city: Katowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 212
city: Kcynia
country: Poland
facility: Boehringer Ingelheim Investigational Site 69
city: Kielce
country: Poland
facility: Boehringer Ingelheim Investigational Site 112
city: Kielce
country: Poland
facility: Boehringer Ingelheim Investigational Site 18
city: Kielce
country: Poland
facility: Boehringer Ingelheim Investigational Site 19
city: Klodzko
country: Poland
facility: Boehringer Ingelheim Investigational Site 13
city: Kolobrzeg
country: Poland
facility: Boehringer Ingelheim Investigational Site 49
city: Konin
country: Poland
facility: Boehringer Ingelheim Investigational Site 219
city: Konskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 141
city: Konskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 142
city: Koszalin
country: Poland
facility: Boehringer Ingelheim Investigational Site 51
city: Koszalin
country: Poland
facility: Boehringer Ingelheim Investigational Site 52
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 122
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 135
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 143
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 146
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 171
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 177
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 214
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 87
city: Krakow
country: Poland
facility: Boehringer Ingelheim Investigational Site 94
city: Krasnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 129
city: Krasnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 204
city: Krasnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 207
city: Krosno
country: Poland
facility: Boehringer Ingelheim Investigational Site 192
city: Kutno
country: Poland
facility: Boehringer Ingelheim Investigational Site 194
city: Ledziny
country: Poland
facility: Boehringer Ingelheim Investigational Site 86
city: Legionowo
country: Poland
facility: Boehringer Ingelheim Investigational Site 97
city: Lisnik Duzy
country: Poland
facility: Boehringer Ingelheim Investigational Site 127
city: Lodz
country: Poland
facility: Boehringer Ingelheim Investigational Site 187
city: Lodz
country: Poland
facility: Boehringer Ingelheim Investigational Site 188
city: Lodz
country: Poland
facility: Boehringer Ingelheim Investigational Site 193
city: Lodz
country: Poland
facility: Boehringer Ingelheim Investigational Site 198
city: Lodz
country: Poland
facility: Boehringer Ingelheim Investigational Site 206
city: Lomza
country: Poland
facility: Boehringer Ingelheim Investigational Site 57
city: Lomza
country: Poland
facility: Boehringer Ingelheim Investigational Site 58
city: Lowicz
country: Poland
facility: Boehringer Ingelheim Investigational Site 186
city: Luban
country: Poland
facility: Boehringer Ingelheim Investigational Site 158
city: Lubartow
country: Poland
facility: Boehringer Ingelheim Investigational Site 37
city: Lubin
country: Poland
facility: Boehringer Ingelheim Investigational Site 172
city: Lubin
country: Poland
facility: Boehringer Ingelheim Investigational Site 173
city: Lubin
country: Poland
facility: Boehringer Ingelheim Investigational Site 196
city: Lubliniec
country: Poland
facility: Boehringer Ingelheim Investigational Site 242
city: Lublin
country: Poland
facility: Boehringer Ingelheim Investigational Site 124
city: Lublin
country: Poland
facility: Boehringer Ingelheim Investigational Site 17
city: Lublin
country: Poland
facility: Boehringer Ingelheim Investigational Site 29
city: Lublin
country: Poland
facility: Boehringer Ingelheim Investigational Site 7
city: Lubon
country: Poland
facility: Boehringer Ingelheim Investigational Site 209
city: Ludwikowo
country: Poland
facility: Boehringer Ingelheim Investigational Site 106
city: Lukow
country: Poland
facility: Boehringer Ingelheim Investigational Site 30
city: Makow Mazowiecki
country: Poland
facility: Boehringer Ingelheim Investigational Site 45
city: Malbork
country: Poland
facility: Boehringer Ingelheim Investigational Site 168
city: Mielec
country: Poland
facility: Boehringer Ingelheim Investigational Site 110
city: Milicz
country: Poland
facility: Boehringer Ingelheim Investigational Site 159
city: Myslowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 150
city: Myszkow
country: Poland
facility: Boehringer Ingelheim Investigational Site 25
city: Nisko
country: Poland
facility: Boehringer Ingelheim Investigational Site 215
city: Nowy Dwor Gdanski
country: Poland
facility: Boehringer Ingelheim Investigational Site 128
city: Nowy Sacz
country: Poland
facility: Boehringer Ingelheim Investigational Site 109
city: Olawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 154
city: Olecko
country: Poland
facility: Boehringer Ingelheim Investigational Site 72
city: Olsztyn
country: Poland
facility: Boehringer Ingelheim Investigational Site 36
city: Opatow
country: Poland
facility: Boehringer Ingelheim Investigational Site 245
city: Ostrowiec Swietokrzyski
country: Poland
facility: Boehringer Ingelheim Investigational Site 114
city: Ostrowiec Swietokrzyski
country: Poland
facility: Boehringer Ingelheim Investigational Site 145
city: Pabianice
country: Poland
facility: Boehringer Ingelheim Investigational Site 237
city: Papowo Biskupie
country: Poland
facility: Boehringer Ingelheim Investigational Site 182
city: Pawonkow
country: Poland
facility: Boehringer Ingelheim Investigational Site 216
city: Piekary Slaskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 189
city: Pietrzykowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 32
city: Pila
country: Poland
facility: Boehringer Ingelheim Investigational Site 40
city: Piotrkow Trybunalski
country: Poland
facility: Boehringer Ingelheim Investigational Site 203
city: Plock
country: Poland
facility: Boehringer Ingelheim Investigational Site 59
city: Pniewy
country: Poland
facility: Boehringer Ingelheim Investigational Site 93
city: Poniatowa
country: Poland
facility: Boehringer Ingelheim Investigational Site 130
city: Poznan
country: Poland
facility: Boehringer Ingelheim Investigational Site 201
city: Poznan
country: Poland
facility: Boehringer Ingelheim Investigational Site 208
city: Poznan
country: Poland
facility: Boehringer Ingelheim Investigational Site 227
city: Poznan
country: Poland
facility: Boehringer Ingelheim Investigational Site 228
city: Poznan
country: Poland
facility: Boehringer Ingelheim Investigational Site 231
city: Prabuty
country: Poland
facility: Boehringer Ingelheim Investigational Site 126
city: Proszowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 218
city: Pruszcz Gdanski
country: Poland
facility: Boehringer Ingelheim Investigational Site 131
city: Przemysl
country: Poland
facility: Boehringer Ingelheim Investigational Site 191
city: Rabka Zdroj
country: Poland
facility: Boehringer Ingelheim Investigational Site 169
city: Radom
country: Poland
facility: Boehringer Ingelheim Investigational Site 117
city: Radom
country: Poland
facility: Boehringer Ingelheim Investigational Site 118
city: Ruda Slaska
country: Poland
facility: Boehringer Ingelheim Investigational Site 151
city: Ruda Slaska
country: Poland
facility: Boehringer Ingelheim Investigational Site 152
city: Ruda Slaska
country: Poland
facility: Boehringer Ingelheim Investigational Site 230
city: Ruda Slaska
country: Poland
facility: Boehringer Ingelheim Investigational Site 82
city: Rumia
country: Poland
facility: Boehringer Ingelheim Investigational Site 180
city: Rumia
country: Poland
facility: Boehringer Ingelheim Investigational Site 239
city: Rumia
country: Poland
facility: Boehringer Ingelheim Investigational Site 5
city: Rybnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 104
city: Rybnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 183
city: Rybnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 83
city: Rzeszow
country: Poland
facility: Boehringer Ingelheim Investigational Site 175
city: Rzeszow
country: Poland
facility: Boehringer Ingelheim Investigational Site 178
city: Sanok
country: Poland
facility: Boehringer Ingelheim Investigational Site 190
city: Sawin
country: Poland
facility: Boehringer Ingelheim Investigational Site 73
city: Sejny
country: Poland
facility: Boehringer Ingelheim Investigational Site 78
city: Siewierz
country: Poland
facility: Boehringer Ingelheim Investigational Site 160
city: Skarzysko Kamienna
country: Poland
facility: Boehringer Ingelheim Investigational Site 241
city: Skawina
country: Poland
facility: Boehringer Ingelheim Investigational Site 157
city: Skoczow
country: Poland
facility: Boehringer Ingelheim Investigational Site 10
city: Skrzyszow
country: Poland
facility: Boehringer Ingelheim Investigational Site 167
city: Slawno
country: Poland
facility: Boehringer Ingelheim Investigational Site 53
city: Slubice
country: Poland
facility: Boehringer Ingelheim Investigational Site 96
city: Slupca
country: Poland
facility: Boehringer Ingelheim Investigational Site 205
city: Sokolowsko
country: Poland
facility: Boehringer Ingelheim Investigational Site 14
city: Sopot
country: Poland
facility: Boehringer Ingelheim Investigational Site 113
city: Sosnowiec
country: Poland
facility: Boehringer Ingelheim Investigational Site 166
city: Sosnowiec
country: Poland
facility: Boehringer Ingelheim Investigational Site 24
city: Srem
country: Poland
facility: Boehringer Ingelheim Investigational Site 107
city: Srem
country: Poland
facility: Boehringer Ingelheim Investigational Site 213
city: Stalowa Wola
country: Poland
facility: Boehringer Ingelheim Investigational Site 125
city: Starachowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 144
city: Starachowice
country: Poland
facility: Boehringer Ingelheim Investigational Site 80
city: Stargard Szczecinski
country: Poland
facility: Boehringer Ingelheim Investigational Site 120
city: Sucha Beskidzka
country: Poland
facility: Boehringer Ingelheim Investigational Site 95
city: Suprasl
country: Poland
facility: Boehringer Ingelheim Investigational Site 16
city: Suwalki
country: Poland
facility: Boehringer Ingelheim Investigational Site 54
city: Suwalki
country: Poland
facility: Boehringer Ingelheim Investigational Site 55
city: Swidnik
country: Poland
facility: Boehringer Ingelheim Investigational Site 1
city: Swiecie
country: Poland
facility: Boehringer Ingelheim Investigational Site 181
city: Sycow
country: Poland
facility: Boehringer Ingelheim Investigational Site 76
city: Szczecinek
country: Poland
facility: Boehringer Ingelheim Investigational Site 26
city: Szczecin
country: Poland
facility: Boehringer Ingelheim Investigational Site 43
city: Szczecin
country: Poland
facility: Boehringer Ingelheim Investigational Site 48
city: Szczecin
country: Poland
facility: Boehringer Ingelheim Investigational Site 61
city: Szczecin
country: Poland
facility: Boehringer Ingelheim Investigational Site 66
city: Szczecin
country: Poland
facility: Boehringer Ingelheim Investigational Site 67
city: Tarnobrzeg
country: Poland
facility: Boehringer Ingelheim Investigational Site 111
city: Tarnobrzeg
country: Poland
facility: Boehringer Ingelheim Investigational Site 224
city: Tarnowskie Gory
country: Poland
facility: Boehringer Ingelheim Investigational Site 200
city: Tarnow
country: Poland
facility: Boehringer Ingelheim Investigational Site 139
city: Tarnow
country: Poland
facility: Boehringer Ingelheim Investigational Site 140
city: Torun
country: Poland
facility: Boehringer Ingelheim Investigational Site 101
city: Torun
country: Poland
facility: Boehringer Ingelheim Investigational Site 70
city: Torun
country: Poland
facility: Boehringer Ingelheim Investigational Site 71
city: Trzcianka Lubuska
country: Poland
facility: Boehringer Ingelheim Investigational Site 220
city: Twardogora
country: Poland
facility: Boehringer Ingelheim Investigational Site 103
city: Tychy
country: Poland
facility: Boehringer Ingelheim Investigational Site 147
city: Tychy
country: Poland
facility: Boehringer Ingelheim Investigational Site 244
city: Uchanie
country: Poland
facility: Boehringer Ingelheim Investigational Site 38
city: Walcz
country: Poland
facility: Boehringer Ingelheim Investigational Site 39
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 100
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 121
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 137
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 161
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 165
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 210
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 223
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 238
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 2
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 3
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 42
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 46
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 74
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 91
city: Warszawa
country: Poland
facility: Boehringer Ingelheim Investigational Site 99
city: Wejherowo
country: Poland
facility: Boehringer Ingelheim Investigational Site 6
city: Wieliczna
country: Poland
facility: Boehringer Ingelheim Investigational Site 199
city: Wielun
country: Poland
facility: Boehringer Ingelheim Investigational Site 235
city: Witonia
country: Poland
facility: Boehringer Ingelheim Investigational Site 197
city: Wloc³awek
country: Poland
facility: Boehringer Ingelheim Investigational Site 65
city: Wodzislaw Slaski
country: Poland
facility: Boehringer Ingelheim Investigational Site 28
city: Wolomin
country: Poland
facility: Boehringer Ingelheim Investigational Site 98
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 102
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 202
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 221
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 62
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 63
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 64
city: Wroclaw
country: Poland
facility: Boehringer Ingelheim Investigational Site 89
city: Zabkowice Slaskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 12
city: Zabkowice Slaskie
country: Poland
facility: Boehringer Ingelheim Investigational Site 9
city: Zabrze
country: Poland
facility: Boehringer Ingelheim Investigational Site 68
city: Zabrze
country: Poland
facility: Boehringer Ingelheim Investigational Site 75
city: Zabrze
country: Poland
facility: Boehringer Ingelheim Investigational Site 77
city: Zagoty
country: Poland
facility: Boehringer Ingelheim Investigational Site 60
city: Zblewo
country: Poland
facility: Boehringer Ingelheim Investigational Site 132
city: Zgierz
country: Poland
facility: Boehringer Ingelheim Investigational Site 195
city: Zielona Gora
country: Poland
facility: Boehringer Ingelheim Investigational Site 15
city: Zielona Gora
country: Poland
facility: Boehringer Ingelheim Investigational Site 47
city: Zielonka k/Warszawy
country: Poland
facility: Boehringer Ingelheim Investigational Site 81
city: Zyrardow
country: Poland
facility: Boehringer Ingelheim Investigational Site 211
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: